Better Quality of Life for People Living with Diabetes Through Validated Innovative Artificial Intelligence Applications
MELISSA aims to innovate diabetes treatment and care for people with insulin-treated diabetes through the development of a clinically validated, efficient and cost-effective Artificial Intelligence-based digital diabetes management solution. This will contribute to every person with insulin-treated diabetes receiving tailored treatment and care according to their individual needs, habits and evolution resulting in a better quality of life.
1 June 2022
7.7 Mil. €